Human germline gene editing will benefit millions by resolving disease burdens – its an ethical necessity.
Savulescu, et.al. 2015 The moral imperative to continue gene editing research on human embryos Julian Savulescu, Jonathan Pugh, Thomas Douglas, Christopher Gyngell Protein Cell 2015, 6(7):476–479 DOI 10.1007/s13238-015-0184-y
Gene editing technologies have enormous potential as a therapeutic tool in the fight against disease. Roughly 6% of all births have a serious birth defect, which is genetic or partly genetic in origin (Christianson et al., 2006). Advanced and precise gene editing techniques could virtually eradicate genetic birth defects, thereby benefiting nearly 8 million children every year. In addition 35% of all deaths are due to chronic diseases, such as cancer and diabetes, in those under 70.1 Gene editing could significantly lower this disease burden thereby benefiting billions of people around the world over time. To intentionally refrain from engaging in life-saving research is to be morally responsible for the foreseeable, avoidable deaths of those who could have benefitted (Singer, 1993). Research into gene-editing is not an option, it is a moral necessity.